{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:01:22Z","timestamp":1792112482093,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T00:00:00Z","timestamp":1384905600000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fondation Leducq and by National Institutes of Health","award":["HL086599"],"award-info":[{"award-number":["HL086599"]}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Merck"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jacc.2012.08.979","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T08:52:50Z","timestamp":1351759970000},"page":"2218-2229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":206,"title":["Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular Events"],"prefix":"10.1016","volume":"60","author":[{"given":"Sotirios","family":"Tsimikas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Santer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Witztum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kiechl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.08.979_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/138161211795049831","article-title":"Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease","volume":"17","author":"Tsimikas","year":"2011","journal-title":"Curr Pharma Des"},{"key":"10.1016\/j.jacc.2012.08.979_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2012.08.979_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2012.08.979_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2012.08.979_bib6","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/01.CIR.103.22.2705","article-title":"High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound","volume":"103","author":"Tuzcu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.08.979_bib7","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.08.979_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/bmm.11.60","article-title":"Oxidized phospholipids on apolipoprotein B-100 (OxPL\/apoB) containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events","volume":"5","author":"Taleb","year":"2011","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.jacc.2012.08.979_bib9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/01.ATV.19.6.1484","article-title":"The natural course of atherosclerosis","volume":"19","author":"Kiechl","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2012.08.979_bib10","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/01.ATV.19.6.1491","article-title":"The natural course of atherosclerosis","volume":"19","author":"Kiechl","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2012.08.979_bib12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/01.CIR.0000141728.23033.B5","article-title":"High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial","volume":"110","author":"Tsimikas","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.08.979_bib13","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.jacc.2006.03.024","article-title":"Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study","volume":"47","author":"Mayr","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1194\/jlr.M600361-JLR200","article-title":"Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events","volume":"48","author":"Tsimikas","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2012.08.979_bib15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.100.11.1154","article-title":"Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study","volume":"100","author":"Kronenberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.08.979_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jacc.2008.02.066","article-title":"Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study","volume":"52","author":"Choi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.12.047","article-title":"Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin","volume":"47","author":"Rodenburg","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib18","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ije\/dyl233","article-title":"Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies","volume":"35","author":"Wood","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/sim.3530","article-title":"Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies","volume":"28","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2012.08.979_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2012.08.979_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2012.08.979_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2012.08.979_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2012.08.979_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nature10449","article-title":"Complement factor H binds malondialdehyde epitopes and protects from oxidative stress","volume":"478","author":"Weismann","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2012.08.979_bib25","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","article-title":"Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition","volume":"96","author":"Chang","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jacc.2012.08.979_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.20031763","article-title":"Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory","volume":"200","author":"Chang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacc.2012.08.979_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2012.08.979_bib28","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1073\/pnas.86.4.1372","article-title":"Low density lipoprotein undergoes oxidative modification in vivo","volume":"86","author":"Palinski","year":"1989","journal-title":"PNAS"},{"issue":"Suppl","key":"10.1016\/j.jacc.2012.08.979_bib29","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1194\/jlr.R800100-JLR200","article-title":"The role of innate immunity in atherogenesis","volume":"50","author":"Hartvigsen","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2012.08.979_bib30","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.jacc.2012.08.979_bib31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1172\/JCI114271","article-title":"Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man","volume":"84","author":"Yla-Herttuala","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2012.08.979_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.08.979_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2009.04.001","article-title":"Clinical significance of the humoral immune response to modified LDL","volume":"134","author":"Lopes-Virella","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jacc.2012.08.979_bib34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1194\/jlr.M015776","article-title":"Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study","volume":"52","author":"Ravandi","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2012.08.979_bib35","first-page":"821","article-title":"Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease","volume":"55","author":"Gounopoulos","year":"2007","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib36","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"Chou","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2012.08.979_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.109.868158","article-title":"Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"120","author":"Lewis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.08.979_bib38","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCRESAHA.111.248542","article-title":"B1a B Lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions","volume":"109","author":"Kyaw","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2012.08.979_bib39","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2011.07.017","article-title":"Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression","volume":"58","author":"Tsimikas","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib40","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","article-title":"Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study","volume":"27","author":"Kiechl","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2012.08.979_bib41","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jacc.2010.04.048","article-title":"Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events","volume":"56","author":"Tsimikas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.08.979_bib42","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study","volume":"119","author":"Tsimikas","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.08.979_bib43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jacl.2011.07.005","article-title":"Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists","volume":"5","author":"Davidson","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacc.2012.08.979_bib44","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.08.979_bib45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCULATIONAHA.111.018820","article-title":"Global variation in the relative burden of stroke and ischemic heart disease\/clinical perspective","volume":"124","author":"Kim","year":"2011","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712043574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712043574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:55:44Z","timestamp":1760014544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712043574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":45,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0735109712043574"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.08.979","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidation-Specific Biomarkers, Prospective 15-Year Cardiovascular and Stroke Outcomes, and Net Reclassification of Cardiovascular Events","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.08.979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}